Long-Term Psychological Impact of Carrying a BRCA1/2 Mutation and Prophylactic Surgery: A 5-Year Follow-Up Study

van Oostrom, Iris, Meijers-Heijboer, Hanne, Lodder, Litanja N., Duivenvoorden, Hugo J., van Gool, Arthur R., Seynaeve, Caroline, van der Meer, Conny A., Klijn, Jan G.M., van Geel, Bert N., Burger, Curt W., Wladimiroff, Juriy W., Tibben, Aad·2003·Journal of Clinical Oncology
DOI 10.1200/jco.2003.10.100

Cited by (281)

Items 101–200 of 281

  1. Unmet support needs and distress among women with a BRCA1/2 mutation
    Ashley Farrelly, VICTORIA M. WHITE, Bettina Meiser, Michael Jefford, Mary‐Anne Young, Sandra Ieropoli, Ingrid Winship, Jessica Duffy · 2012 · Familial Cancer
  2. Survivorship considerations in adults with hereditary breast and ovarian cancer syndrome: state of the science
    Cheryl B. Crotser, Marcia M. Boehmke · 2009 · Journal of Cancer Survivorship
  3. Unraveling the Next Chapter
    Ellen T. Matloff, Rachel E. Barnett, Sharon L. Bober · 2009 · The Cancer Journal
  4. Standard psychological consultations and follow up for women at increased risk of hereditary breast cancer considering prophylactic mastectomy
    Tan, Murly BM, Bleiker, Eveline MA, Menke-Pluymers, Marian BE, Van Gool, Arthur R, van Dooren, Silvia, Van Geel, Bert N, Tilanus-Linthorst, Madeleine MA, Bartels, Karina CM, Klijn, Jan GM, Brekelmans, Cecile TM et al. · 2009 · Hereditary Cancer in Clinical Practice
  5. Genetic testing in familial melanoma: uptake and implications
    Femke A. de Snoo, Sam R. Riedijk, Anneke M. van Mil, Wilma Bergman, Jeanet ter Huurne, Reinier Timman, Wieke Bertina, Nelleke A. Gruis, Hans F. A. Vasen, Arie van Haeringen et al. · 2008 · Psycho-Oncology
  6. Evaluation of Sexual Function in Patients with Gynecologic Cancer and Evidence-Based Nursing Interventions
    Ümran Öskay, Nezihe Kızılkaya Beji, Meltem Demirgöz Bal, Sema Dereli Yılmaz · 2010 · Sexuality and Disability
  7. Emotional impact on the results of BRCA1 and BRCA2 genetic test: an observational retrospective study
    Sara Mella, Barbara Muzzatti, Riccardo Dolcetti, Maria Antonietta Annunziata · 2017 · Hereditary Cancer in Clinical Practice
  8. The impact of social and personal resources on psychological distress in women at risk for hereditary breast cancer
    Mariska den Heijer, Joël Vos, Caroline Seynaeve, Kathleen Vanheusden, Hugo Joseph Duivenvoorden, Madeleine A Tilanus-Linthorst, Marian B. E. Menke‐Pluymers, Aad Tibben · 2010 · Psycho-Oncology
  9. Predictors of psychological distress among individuals with a strong family history of malignant melanoma
    Nadine Angele Kasparian, Bettina Meiser, Phyllis Noemi Butow, JM Simpson, Graham J. Mann · 2007 · Clinical Genetics
  10. Breast Cancer, BRCA Mutations, and Attitudes Regarding Pregnancy and Preimplantation Genetic Diagnosis
    Ashley Woodson, Kimberly I. Muse, Heather Yan Lin, Michelle Jackson, Danielle N. Mattair, Leslie R. Schover, Terri Lynn Woodard, Laurie Jane McKenzie, Richard L. Theriault, Gabriel N. Hortobágyi et al. · 2014 · The Oncologist
  11. Review Article
    Paige E. Tucker, Paul Andrew Cohen · 2017 · International Journal of Gynecological Cancer
  12. Improving follow up after predictive testing in Huntington’s disease: evaluating a genetic counselling narrative group session
    Cheryl L. Stopford, Mariangels Ferrer‐Duch, Ramona Moldovan, Rhona MacLeod · 2019 · Journal of Community Genetics
  13. Psychological distress in newly diagnosed colorectal cancer patients following microsatellite instability testing for Lynch syndrome on the pathologist’s initiative
    Karin M. Landsbergen, Judith B. Prins, Han G. Brunner, Peter van Duijvendijk, Fokko M. Nagengast, J. Han van Krieken, Marjolijn J. L. Ligtenberg, Nicoline Hoogerbrugge · 2012 · Familial Cancer
  14. Randomized Controlled Trial of a Telephone-Based Peer-Support Program for Women Carrying aBRCA1orBRCA2Mutation: Impact on Psychological Distress
    VICTORIA M. WHITE, Mary‐Anne Young, Ashley Farrelly, Bettina Meiser, Michael Jefford, Elizabeth Williamson, Sandra Ieropoli, Jessica Duffy, Ingrid Winship · 2014 · Journal of Clinical Oncology
  15. Emotional and sexual concerns in women undergoing pelvic surgery and associated treatment for gynecologic cancer.
    Cara Stabile, Abigail Gunn, Yukio Sonoda, Jeanne Carter · 2015 · PubMed Central
  16. Uptake of prenatal diagnostic testing for retinoblastoma compared to other hereditary cancer syndromes in the Netherlands
    Charlotte J. Dommering, Lidewij Henneman, Annemarie H. van der Hout, Marianne A. Jonker, Carli M.J. Tops, Ans M.W. van den Ouweland, Rob B. van der Luijt, Arjen R. Mensenkamp, Frans B.L. Hogervorst, Egbert J. W. Redeker et al. · 2016 · Familial Cancer
  17. Contralateral Prophylactic Mastectomy: Caveat Emptor
    Abram Recht · 2009 · Journal of Clinical Oncology
  18. Interventions to improve psychosocial well-being in female BRCA-mutation carriers following risk-reducing surgery
    Lisa Jeffers, Joanne Reid, Donna Fitzsimons, Patrick J. Morrison, Martin Dempster · 2019 · Cochrane Database of Systematic Reviews
  19. A Systematic Review on Cost-effectiveness Studies Evaluating Ovarian Cancer Early Detection and Prevention Strategies
    Gaby Sroczynski, Artemisa Gogollari, Felicitas Kuehne, Lára R. Hallsson, Martin Widschwendter, Nora Pashayan, Uwe Siebert · 2020 · Cancer Prevention Research
  20. Predictors of decision making in families at risk for inherited breast/ovarian cancer.
    Suzanne Mellon, James J. Janisse, Robin B. Gold, Michelle Cichon, Lisa Berry‐Bobovski, Michael A. Tainsky, Michael Steven Simon · 2009 · Health Psychology
  21. Female BRCA mutation carriers with a preference for prophylactic mastectomy are more likely to participate an educational-support group and to proceed with the preferred intervention within 2 years
    Karin M. Landsbergen, Judith B. Prins, Yvonne J. L. Kamm, Han G. Brunner, Nicoline Hoogerbrugge · 2009 · Familial Cancer
  22. Time to decide about risk-reducing mastectomy: A case series of BRCA1/2 gene mutation carriers
    Mary McCullum, Joan L. Bottorff, Mary T. Kelly, Stephanie A. Kieffer, Lynda G. Balneaves · 2007 · BMC Women s Health
  23. Challenges in managing genetic cancer risk: a long-term qualitative study of unaffected women carrying BRCA1/BRCA2 mutations
    Maria Caiata Zufferey, Olivia Pagani, Viviane Cina, Véronique Membrez, Monica Taborelli, Sheila Unger, Anne E. Murphy, Christian Monnerat, Pierre Olivier Chappuis · 2014 · Genetics in Medicine
  24. Perspectives of Women Considering Bilateral Prophylactic Mastectomy and their Peers towards a Telephone‐Based Peer Support Intervention
    Dominique St-Pierre, Karine Bouchard, Lynn R. Gauthier, Jocelyne Chiquette, Michel Dorval · 2017 · Journal of Genetic Counseling
  25. Oncogénétique: estimation des besoins de la population en France pour les dix ans à venir
    Catherine Bonaïti‐Pellié, N. Andrieu, Patrick Arveux, Valérie Bonadona, Bruno Buecher, Marc Delpech, Damien Jolly, Claire Julian‐Reynier, É. Luporsi, Catherine Noguès et al. · 2009 · Bulletin du Cancer
  26. Long‐term cohort study of women at intermediate risk of familial breast cancer: experiences of living at risk
    Paul D. Bennett, Evelyn P. Parsons, Kate E. Brain, Kerenza Hood, on behalf of the reTrace Study Team · 2009 · Psycho-Oncology
  27. Distress, anxiety, and depression in persons with hereditary cancer syndromes: Results from a nationwide cross‐sectional study in Germany
    Anna Maria Kastner, Josefine Fischer‐Jacobs, Jan Brederecke, Andrea Hahne, Tanja Zimmermann · 2023 · Cancer Medicine
  28. A Multi‐Case Report of the Pathways To and Through Genetic Testing and Cancer Risk Management forBRCAMutation‐Positive Women Aged 18–25
    Lindsey M. Hoskins, Allison Werner‐Lin · 2012 · Journal of Genetic Counseling
  29. A Counselling Model for BRCA1/2 Genetic Susceptibility Testing
    Iris van Oostrom, Aad Tibben · 2004 · Hereditary Cancer in Clinical Practice
  30. Anxiety and depression symptoms among women attending group-based patient education courses for hereditary breast and ovarian cancer
    Wenche Listøl, Hildegunn Høberg‐Vetti, Geir Egil Eide, Cathrine Bjorvatn · 2017 · Hereditary Cancer in Clinical Practice
  31. Inherited Medullary Thyroid Cancer and the Duty to Warn: Revisiting Pate v. Threlkel in Light of HIPAA
    M. Sara Rosenthal, Heather Pierce · 2005 · Thyroid
  32. Psychosocial outcomes and counselee satisfaction following genetic counseling for hereditary breast and ovarian cancer: A patient-reported outcome study
    Anne Oberguggenberger, Monika Judith Sztankay, Raphael J. Morscher, Barbara Sperner‐Unterweger, Ingrid B. Weber, Michael Hubalek, Georg Kemmler, Johannes Zschocke, Caroline Lopes Martini, Daniel Egle et al. · 2016 · Journal of Psychosomatic Research
  33. Living With Genetic Vulnerability: a Life Course Perspective
    Rebekah Hamilton, Nancy A. Innella, Dawn T. Bounds · 2015 · Journal of Genetic Counseling
  34. Experiences of Genetic Counseling forBRCA1/2Among Recently Diagnosed Breast Cancer Patients: A Qualitative Inquiry
    Susan Thomas Vadaparampil, Gwendolyn P. Quinn, Jennifer Brzosowicz, Cheryl A. Miree · 2008 · Journal of Psychosocial Oncology
  35. Relationship satisfaction predicts sexual activity following risk-reducing salpingo-oophorectomy
    Tierney K. Lorenz, Bonnie McGregor, Elizabeth M. Swisher · 2014 · Journal of Psychosomatic Obstetrics & Gynecology
  36. Cost-Effectiveness of Early Detection and Prevention Strategies for Endometrial Cancer—A Systematic Review
    Gaby Sroczynski, Artemisa Gogollari, Annette Conrads‐Frank, Lára R. Hallsson, Nora Pashayan, Martin Widschwendter, Uwe Siebert · 2020 · Cancers
  37. Patient reported outcomes after risk-reducing surgery in patients at increased risk of ovarian cancer
    Lauren Philp, Stephanie Alimena, Winslow Ferris, A. Saini, Amy J. Bregar, M.G. del Carmen, Eric Lawernce Eisenhauer, Whitfield B. Growdon, Annekathryn Goodman, K.M. Dorney et al. · 2021 · Gynecologic Oncology
  38. Am I My Genes? Perceived Genetic Etiology, Intrapersonal Processes, and Health
    Benjamin Y. Cheung, Ilan Dar‐Nimrod, Karen Gonsalkorale · 2014 · Social and Personality Psychology Compass
  39. Identifying Needs: a Qualitative Study of women's Experiences Regarding Rapid Genetic Testing for Hereditary Breast and Ovarian Cancer in the DNA BONus Study
    Mirjam Tonheim Augestad, Hildegunn Høberg‐Vetti, Cathrine Bjorvatn, Ragnhild Johanne Tveit Sekse · 2016 · Journal of Genetic Counseling
  40. The Cancer Worry Scale Revised for Breast Cancer Genetic Counseling
    Anita Caruso, Cristina Vigna, Paola Gremigni · 2017 · Cancer Nursing
  41. Who is prone to high levels of distress after prophylactic mastectomy and/or salpingo-ovariectomy?
    Bresser, P.J.C., Van Gool, A.R., Seynaeve, C., Duivenvoorden, H.J., Niermeijer, M.F., van Geel, A.N., Menke, M., Klijn, J.G.M., Tibben, A. · 2007 · Annals of Oncology
  42. Building the Cancer Family: Family Planning in the Context of Inherited Breast and Ovarian Cancer Risk
    A. Werner-Lin · 2010 · Journal of the Society for Social Work and Research
  43. Living with the BRCA1 and BRCA2 genetic mutation: Learning how to adapt to a virtual chronic illness
    André Samson, Julia DiMillo, Anne Thériault, S. Lowry, Linda Corsini, S. Verma, Eva M. Tomiak · 2013 · Psychology Health & Medicine
  44. Development and validation of an instrument to measure the impact of genetic testing on self-concept in Lynch syndrome
    M. J. Esplen, Noreen Stuckless, Steve Gallinger, Melyssa D. Aronson, Heidi Rothenmund, Kara Semotiuk, Jacqueline Stokes, Christine Y. Way, Julie B. Green, Kate Butler et al. · 2011 · Clinical Genetics
  45. Study on the psychosocial aspects of risk-reducing salpingo-oophorectomy (RRSO) in BRCA1/2 mutation carriers in Japan: a preliminary report
    Mika Shigehiro, Mizuho Kita, Sayoko Takeuchi, Yuumi Ashihara, Masami Arai, Hitoshi Okamura · 2015 · Japanese Journal of Clinical Oncology
  46. Genotype Phenotype Correlation in Li-Fraumeni Syndrome Kindreds and its Implications for Management
    Russell N. Moule, Sameer G. Jhavar, Rosalind A. Eeles · 2006 · Familial Cancer
  47. Prophylactic mastectomy: the Rotterdam experience
    Albertus N. van Geel · 2003 · The Breast
  48. BRCA genetic testing of individuals from families with low prevalence of cancer: experiences of carriers and implications for population screening
    S. Shkedi-Rafid, E. Gabai-Kapara, J. Grinshpun‐Cohen, E. Levy-Lahad · 2012 · Genetics in Medicine
  49. Group medical visits in the follow-up of women with a BRCA mutation: design of a randomized controlled trial
    Annemiek Visser, Judith B. Prins, Nicoline Hoogerbrugge, Hanneke W.M. van Laarhoven · 2011 · BMC Women s Health
  50. Genetics: Breast Cancer as an Exemplar
    Rebekah Hamilton · 2009 · Nursing Clinics of North America
  51. Opinions of women with high inherited breast cancer risk about prophylactic mastectomy: an initial evaluation from a screening trial including magnetic resonance imaging and ductal lavage
    Allison W. Kurian, Anne‐Renee Hartman, Meredith A. Mills, James M. Ford, Bruce Lewis Daniel, Sylvia K. Plevritis · 2005 · Health Expectations
  52. The research landscape of the quality of life or psychological impact on gynecological cancer patients: A bibliometric analysis
    Jiayuan Zhao, Yujia Kong, Yang Xiang, Junjun Yang · 2023 · Frontiers in Oncology
  53. Decision Making and Distress Among Individuals Diagnosed with Follicular Lymphoma
    Jennifer L. Kilkus, John W. Hayslip, Jamie L. Studts · 2012 · Journal of Psychosocial Oncology
  54. Patient-Reported Outcome Measures may optimize shared decision-making for cancer risk management in BRCA mutation carriers
    Laurentine S. E. van Egdom, M. A. de Kock, Inge Apon, Marc A.M. Mureau, Cornelis Kees Verhoef, Jan Antonius Hazelzet, Linetta B. Koppert · 2019 · Breast Cancer
  55. Which factors predict proposal and uptake of psychological counselling after BRCA1/2 test result disclosure?
    Christine Maheu, Anne‐Déborah Bouhnik, Catherine Noguès, Emmanuelle Mouret‐Fourme, Dominique Stoppa‐Lyonnet, Christine Lasset, Pascaline Berthet, Jean‐Pierre Fricker, Olivier Caron, E. Luporsi et al. · 2013 · Psycho-Oncology
  56. Genetic testing: When prediction generates stigmatization
    Julia DiMillo, André Samson, Anne Thériault, S. Lowry, Linda Corsini, Shailendra Verma, Eva M. Tomiak · 2013 · Journal of Health Psychology
  57. Coping Mechanisms, Psychological Distress, and Quality of Life Prior to Cancer Genetic Counseling
    Valentina Elisabetta Di Mattei, Letizia Carnelli, Martina Bernardi, Rebecca Bienati, Chiara Brombin, Federica Cugnata, Emanuela Rabaiotti, Milvia Zambetti, Laura Sarno, Massimo Candiani et al. · 2018 · Frontiers in Psychology
  58. The withdrawal from oncogenetic counselling and testing for hereditary and familial breast and ovarian cancer. A descriptive study of an Italian sample
    Anita Caruso, Cristina Vigna, Gabriella Maggi, Fabio Massimo Sega, Francesco Cognetti, Antonella Savarese · 2008 · Journal of Experimental & Clinical Cancer Research
  59. Cancer risk comparative perception and overscreening behaviours of non-carriers from BRCA1/2 families
    Isabelle Milhabet, Christelle Duprez, Aurélie Krzeminski, Véronique Christophe · 2013 · European Journal of Cancer Care
  60. Challenges and Opportunities for Cancer Predisposition Cascade Screening for Hereditary Breast and Ovarian Cancer and Lynch Syndrome in Switzerland: Findings from an International Workshop
    Christos Nikolaidis, Chang Ming, Carla Pedrazzani, Tina van der Horst, Andrea Patricia Kaiser-Grolimund, Zanfina Ademi, Rosmarie Bührer-Landolt, Nicole Bürki, Maria Caiata Zufferey, Victoria Lee Champion et al. · 2018 · Public Health Genomics
  61. Is the psychological impact of genetic testing moderated by support and sharing of test results to family and friends?
    GENEPSO Cohort, Julie Lapointe, Michel Dorval, Catherine Noguès, Roxane Fabre, Claire Julian‐Reynier · 2013 · Familial Cancer
  62. Making the Decision to Participate in Predictive Genetic Testing for Arrhythmogenic Right Ventricular Cardiomyopathy
    April D. Pike, Fern Brunger · 2014 · Journal of Genetic Counseling
  63. Decisions and outcomes of genetic testing for inherited breast cancer risk
    Chanita Hughes Halbert · 2004 · Annals of Oncology
  64. Changes in Specialists’ Perspectives on Cancer Genetic Testing, Prophylactic Surgery and Insurance Discrimination: Then and Now
    Ellen T. Matloff, Danielle C. Bonadies, Anne E. Moyer, Karina L. Brierley · 2013 · Journal of Genetic Counseling
  65. Concerns and Expectations of Risk-Reducing Surgery in Women with Hereditary Breast and Ovarian Cancer Syndrome
    Paola Modaffari, Riccardo Ponzone, Alberta Ferrari, Isabella Cipullo, Viola Liberale, Marta D’Alonzo, Furio Maggiorotto, Nicoletta Biglia · 2019 · Journal of Clinical Medicine
  66. The evolution of worry after breast cancer risk assessment: 6‐year follow‐up of the TRACE study cohort
    Kate E. Brain, Evelyn P. Parsons, Paul D. Bennett, Rebecca L. Cannings-John, Kerenza Hood · 2010 · Psycho-Oncology
  67. Psychological Aspects of Hereditary Cancer Risk Counseling and Genetic Testing
    Lisa G. Aspinwall, Jennifer M. Taber, Wendy K. Kohlmann, Sancy Ann Leachman · 2012 · Springer eBooks
  68. Methodology in longitudinal studies on psychological effects of predictive DNA testing: a review
    Reinier Timman, T Stijnen, Aad Tibben · 2004 · Journal of Medical Genetics
  69. Assessing Psychological Morbidity in Cancer-Unaffected BRCA1/2 Pathogenic Variant Carriers: A Systematic Review
    Anna Isselhard, Zoë Lautz, Kerstin Rhiem, Stephanie Stock · 2023 · Current Oncology
  70. Using polygenic risk modification to improve breast cancer prevention: study protocol for the PRiMo multicentre randomised controlled trial
    Simone McInerny, Lyon Mascarenhas, Tatiane Yanes, Lara Petelin, Georgia Chenevix‐Trench, Melissa C. Southey, Mary‐Anne Young, Paul Andrew James · 2024 · BMJ Open
  71. Breast cancer genetic counselling referrals: how comparable are the findings between the UK and the Netherlands?
    Akke Albada, Julie Werrett, Sandra van Dulmen, Jozien M. Bensing, Cyril J. Chapman, Margreet G.E.M. Ausems, Alison Metcalfe · 2011 · Journal of Community Genetics
  72. Impact cognitif, émotionnel et comportemental d’un résultat BRCA1/2 incertain : revue de la littérature
    Débora Leblond, Anne Brédart, Sylvie Dolbeault, Antoine De Pauw, Dominique Stoppa‐Lyonnet, Cécile Flahault, Serge Sultan · 2011 · Bulletin du Cancer
  73. 1–2 Impact of BRCA1/BRCA2 Counseling and Testing on Newly Diagnosed Breast Cancer Patients
    Lisa A. Newman · 2005 · Breast Diseases A Year Book Quarterly
  74. Shortened time interval between colorectal cancer diagnosis and risk testing for hereditary colorectal cancer is not related to higher psychological distress
    Karin M. Landsbergen, Judith B. Prins, Han G. Brunner, Nicoline Hoogerbrugge · 2010 · Familial Cancer
  75. Non-invasive proteomics—thinking about personalized breast cancer screening and treatment
    Manuel Debald, Matthias Wolfgarten, Gisela Walgenbach‐Brünagel, Walther Christian Kuhn, Michael Braun · 2010 · The EPMA Journal
  76. DNA-testing for BRCA1/2 prior to genetic counselling in patients with breast cancer: design of an intervention study, DNA-direct
    Aisha S. Sie, Liesbeth Spruijt, Wendy A.G. van Zelst–Stams, Arjen R. Mensenkamp, Marjolijn J. L. Ligtenberg, Han G. Brunner, Judith B. Prins, Nicoline Hoogerbrugge · 2012 · BMC Women s Health
  77. Psychosocial outcomes after varying risk management strategies in women at increased familial breast cancer risk: a mixed methods study of patient and partner outcomes
    Jenna L. Morgan, E MacInnes, Sally E. Erskine, Stephen J. Walters, Jackie A Cook, Karen Collins, Lynda Wyld · 2023 · Annals of The Royal College of Surgeons of England
  78. Incidence and predictors of positive and negative effects of BRCA1/2 genetic testing on familial relationships: a 3-year follow-up study
    Julie Lapointe, Karine Bouchard, Andrea Farkas Patenaude, Elizabeth Maunsell, Jacques Simard, Michel Dorval · 2012 · Genetics in Medicine
  79. Choosing high-risk screening vs. surgery and the effect of treatment modality on anxiety and breast-specific sensuality in BRCA mutation carriers
    Kristin Emilia Rojas, Elizabeth Butler, de Castro Gutiérrez J, Rebecca M. Kwait, Jessica Kent Laprise, Jennifer Scalia Wilbur, Sarah Spinette, Christina Raker, Katina M. Robison, Robert Duffy Legare et al. · 2019 · Gland Surgery
  80. Intentions to share exome sequencing results with family members: exploring spousal beliefs and attitudes
    Erin Turbitt, Megan Clarke Roberts, Rebecca A. Ferrer, Jennifer M. Taber, Katie L Lewis, Leslie G. Biesecker, Barbara Bowles Biesecker, William M. P. Klein · 2018 · European Journal of Human Genetics
  81. “Peace of Mind” After Mastectomy: A Scoping Review
    Safraz A. Hamid, Baylee F. Bakkila, Kurt S. Schultz, Alyssa Ann Grimshaw, Craig G. Gunderson, Elizabeth Louise Godfrey, Clara Lee, Elizabeth Rapp Berger, Shoshana M. Rosenberg, Rachel A. Greenup · 2024 · Annals of Surgical Oncology
  82. Prophylactic and Therapeutic Breast Conservation inBRCA1/2Mutation Carriers
    Randal L. Croshaw, Megan L. Marshall, Tesha L. Williams, Kathleen M. Erb, Thomas B. Julian · 2011 · International Journal of Breast Cancer
  83. Management of Genetic Syndromes Predisposing to Gynecologic Cancers
    Susan Miesfeldt, Amanda E. Lamb, Christine W. Duarte · 2013 · Current Treatment Options in Oncology
  84. The Relationship Between Psychological Distress and Personality in Women from Families with Familial Breast/Ovarian or Hereditary Non‐polyposis Colorectal Cancer in the Absence of Demonstrated Mutations
    Amy Østertun Geirdal, Alv Andreas Dahl · 2008 · Journal of Genetic Counseling
  85. Ethical, Legal, Psychosocial, and Cultural Implications of Genomics for Oncology Nurses
    John G. Twomey · 2011 · Seminars in Oncology Nursing
  86. Psychometric properties of a French version of a Dutch scale for assessing breast and body image (BBIS) in healthy women
    Noémie Resseguier, Catherine Noguès, Roch Giorgi, Claire Julian‐Reynier · 2013 · BMC Women s Health
  87. Acceptance of Prophylactic Surgery and Chemoprevention of Cancer in Singapore – A Survey
    HT See, Yin Bun Cheung, F Yong, KS Khoo, Peter Ang · 2005 · Annals of the Academy of Medicine Singapore
  88. Test-takers’ perspectives on consumer genetic testing for hereditary cancer risk
    Madison K. Kilbride, Lisa Jay Kessler, Brigitte Cronier, Jacqueline J. Park, Cara N. Cacioppo, Jordyn Beem, Angela R. Bradbury · 2024 · Frontiers in Genetics
  89. Active approach for breast cancer genetic counseling during radiotherapy: long‐term psychosocial and medical impact
    Jessica E. Baars, Eveline M. A. Bleiker, Els Van Riel, C.C. Rodenhuis, Mary E. Velthuizen, Kathryn J. Schlich‐Bakker, Margreet G.E.M. Ausems · 2013 · Clinical Genetics
  90. The factors associated with distress a minimum of six months after BRCA1/2 confirmation: A systematic review
    Ellen Butler, Sonya Collier, David Hevey · 2020 · Journal of Psychosocial Oncology
  91. The BRCA1/2 Previvor Information Journey: Understanding What Helps or Hinders
    Josephine K. Boumis, Marleah Dean · 2023 · Health Communication
  92. Cancers et terrain familial: impacts psychologiques du risque de transmission d’un gène muté
    L. Basset, J. Masson, Amal Bernoussi, Michel Wawrzyniak · 2013 · Psycho-Oncologie
  93. Concerns about unintended negative consequences of informing the public about multifactorial risks may be premature for young adult smokers
    Erika A. Waters, Caroline Kincaid, Annette R. Kaufman, Michelle L. Stock, Laurel M. Peterson, Nicole L. Muscanell, Rosanna E. Guadagno · 2013 · British Journal of Health Psychology
  94. Cancer Genetic Counselees’ Self‐Reported Psychological Distress, Changes in Life, and Adherence to Recommended Surveillance Programs 3–7 Years Post Counseling
    Afsaneh Hayat Roshanai, Richard Rosenquist, Claudia Lampic, Karin Nordin · 2009 · Journal of Genetic Counseling
  95. Participation of Korean families at high risk for hereditary breast and ovarian cancer in BRCA1/2 genetic testing
    Yuan‐Wan Sun, Eunyoung Kang, Hyunnam Baek, Jong-myung Jung, E. Hwang, J. Koo, E.-K. Kim, Sangwoo Kim · 2015 · Japanese Journal of Clinical Oncology
  96. The introduction of a choice to learn pre‐symptomatic DNA test results for BRCA or Lynch syndrome either face‐to‐face or by letter
    Jan S. Voorwinden, Jpc Jaspers, JG ter Beest, Y Kievit, Rolf H. Sijmons, JC Oosterwijk · 2011 · Clinical Genetics
  97. Mechanism of cytokinesis failure in ovarian cystadenomas with defective BRCA1 and P53 pathways
    Theresa Austria, Christine M. Marion, Vanessa Yu, Martin Widschwendter, David R. Hinton, Louis Dubeau · 2018 · International Journal of Cancer
  98. Psychosocial and Ethical Issues Relating to Genetic Testing for BRCA1 and BRCA2 Breast Cancer Susceptibility Genes
    Erin Winchester, Shirley Victoria Hodgson · 2006 · Women s Health
  99. The Angelina Jolie Effect in Jewish Law: Prophylactic Mastectomy and Oophorectomy in BRCA Carriers
    Sharon Galper Grossman · 2015 · Rambam Maimonides Medical Journal
  100. Communication with Family Members about Positive BRCA1/2 Genetic Test Results in Korean Hereditary Breast Cancer Families
    Eunyoung Kang, Sung Sup Park, Ku Sang Kim, Doo Ho Choi, Seok Jin Nam, Nam Sun Paik, Jong Won Lee, Min Hyuk Lee, Sung‐Won Kim, Korean Breast Cancer Society · 2011 · Journal of genetic medicine